Clinical Trial Update: Psilocybin in Adults With and Without Autism Spectrum Disorder [NA]

View source ↗

Summary

King's College London completed a clinical trial evaluating psilocybin in adults with and without autism spectrum disorder. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: King's College London | Conditions: Autism Spectrum Disorder | NA | Status: COMPLETED